Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from The United Laboratories International Holdings ( (HK:3933) ) is now available.
The United Laboratories International Holdings Limited announced that its Cefotaxime Sodium for Injection has passed the quality and efficacy consistency evaluation by the China National Medical Products Administration. This approval reinforces the company’s leadership in the anti-infective field and is expected to enhance its value creation for shareholders through continued research and development of new products.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, primarily operating in the pharmaceutical industry. It focuses on the development and production of generic drugs, with a significant market presence in anti-infective medications.
YTD Price Performance: -9.81%
Average Trading Volume: 9,785
Technical Sentiment Signal: Sell
Current Market Cap: $2.93B
For a thorough assessment of 3933 stock, go to TipRanks’ Stock Analysis page.